Adapt Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.4M Sell
1,524
-62
-4% -$62.9K 0.51% 36
2025
Q4
$1.7M Sell
1,586
-63
-4% -$60.2K 0.59% 33
2025
Q3
$1.26M Buy
1,649
+207
+14% +$154K 0.46% 38
2025
Q2
$1.12M Buy
1,442
+30
+2% +$23.3K 0.5% 28
2025
Q1
$1.17M Hold
1,412
0.57% 26
2024
Q4
$1.09M Hold
1,412
0.54% 33
2024
Q3
$1.25M Hold
1,412
0.67% 29
2024
Q2
$1.28M Sell
1,412
-56
-4% -$44.8K 0.8% 28
2024
Q1
$1.14M Buy
+1,468
New +$1.04M 0.81% 24

Other funds holding LLY

Adapt Wealth Advisors's LLY Position: Q1 2026 in Review

Adapt Wealth Advisors reduced its Eli Lilly (LLY) stake by 3.9% in Q1 2026, selling an estimated $62.9K and leaving 1,524 shares worth $1.4M. The position accounts for 0.51% of the portfolio, ranked #36.

Adapt Wealth Advisors first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.7M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Adapt Wealth Advisors held 1,524 shares of Eli Lilly worth $1.4M as of Q1 2026.
  • Adapt Wealth Advisors sold 62 Eli Lilly shares in Q1 2026, an estimated $62.9K.
  • Eli Lilly made up 0.51% of Adapt Wealth Advisors's portfolio in Q1 2026, its #36 holding.
  • Adapt Wealth Advisors first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
  • Adapt Wealth Advisors's Eli Lilly position peaked at $1.7M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Adapt Wealth Advisors's 13F filing for Q1 2026, filed 11 May 2026.